Geometry.Net - the online learning center
Home  - Health_Conditions - Macular Degeneration Bookstore
Page 8     141-159 of 159    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8 
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Macular Degeneration:     more books (101)
  2. Omega-3 fats may cut macular degeneration risk.(Geriatrics): An article from: Internal Medicine News by Melinda Tanzola, 2006-10-15

141. Judy's Jolts Of Hope
A collection of essays describing a journey towards acceptance of the devastating eye disease, macular degeneration. Written to offer hope for people with sudden vision loss.
JUDY'S JOLTS OF HOPE For Macular Degenerates LEARNING TO HOPE Learning to hope takes practice and perseverance
As we stumble down this long path of endurance. Learning to hope is like a child learning to play
With giving and sharing essential for each and every day. Learning to hope requires the hand of a friend
Who is not afraid to say what is just around the bend. Learning to hope means digging deep in our soul
Praying not to find again a big black dark hole. Learning to hope is, for some, a far off illusion
But attainable with the courage to face our visual confusion.
Previous 5 Sites
Previous Next ... List Sites Ringmaster: Dan Roberts

142. Macular Degeneration | AOA
Macular Degeration Eye Diseases, macular degeneration is the leadingcause of blindness in America. It results from changes to

143. Macular Degeneration Research
Information on research into the genetic causes of agerelated macular degeneration. Research based at Cedars-Sinai hospital.
Research Overview Macular Degeneration Diabetic Retinopathy Ocular Herpes Keratoconus Molecular Ophthalmology Refractive Laser Infants and Children Clinical Trials Our Scientists
Macular Degeneration
A normal retina (left) and one with severe macular degeneration.
New Insights For Macular Degeneration "At the present time, it is not known what causes age-related macular degeneration (AMD) and more importantly, what can be done to prevent it," relates Discovery Fund scientist John Ong, Ph.D. "What is known is that there are a number of risk factors that increase a person's chance of getting AMD." The macula is the point of central vision on the retina needed for reading, driving, identifying faces, watching TV, and most other routine activities. AMD destroys the sharp central vision required for reading, driving and recognizing faces. Vision blurs and dims until only a ring of peripheral sight remains. At present 10 million Americans show signs of the disease. As many as 20% of people over age 60 develop AMD. Over age 75, the risk jumps dramatically to 40%. When the "baby-boom" generation reaches this milestone, we will be faced with an epidemic of perhaps 21 million Americans with vision loss from AMD. From Left: John Ong, Ph.D., Hamdi Hamdi, Ph.D., Yadahat Hedvat, M.D.

144. Macular Degeneration (age Related) - (No 68)
macular degeneration (age related) (No 68). NICE has issued guidanceto the NHS in England and Wales on the use of photodynamic

145. Virtual Hospital : Health Topics A-Z : Macular Degeneration
Health Topics AZ macular degeneration. University of Iowa Family Practice HandbookRetina For Adult Patients. macular degeneration Frequently Asked Questions
Health Topics A-Z
Macular Degeneration
All Topics Adult Patient Topics Adult Provider Topics Pediatric Patient Topics ... Pediatric Provider Topics
For Adult Providers
University of Iowa Family Practice Handbook: Retina
For Adult Patients
Macular Degeneration: Frequently Asked Questions
All Topics
Adult Patient Topics Adult Provider Topics ... UI Health Care Home

146. MD Simulator
The MD Simulator is a software program that dynamically simulates the visual implications of macular degeneration.
About OD


Aniseikonia Inspector
Color Vision Recorder

MD Simulator
Contact us
Products: MD Simulator What is MD / Product description / Screen shots Downloads Requirements Testimonials ... Order Short product description
The MD Simulator is a Windows software program that dynamically shows the visual implications of Macular Degeneration. Usually MD is explained with a static picture showing a simple blind spot somewhere in the field. However, this does not always explain well the problems an MD patient experiences. In the MD Simulator the blind spot is calculated in real-time and includes aspects like blurring, distortion, and intensity reduction. Furthermore the blind spot can be coupled to the gaze direction (by moving the mouse). This results in a better explanation of the vision limitations of an MD patient.
Software operation
Using the software is very easy and basically exists of the following two steps:
  • Determine if you'd like to change the current simulation parameter settings (MD stage, etc.). Click on one of the images. This will open the image with the blind spot coupled to the mouse position. You can change the parameter settings and image while you run the simulation.

147. Age-related Macular Degeneration.
GUIDELINE TITLE. Agerelated macular degeneration. BIBLIOGRAPHIC SOURCE(S). Angiography.Low-risk non-neovascular age-related macular degeneration. No. No.

148. Macular Degeneration File: Late-Breaking Research
Updated regularly over 100 descriptions of the latest treatments for agerelatedmacular degeneration—from ophthalmalogy specialists worldwide.
The Macular Degeneration File SM
Home Page
Seal of Approval
The Patient's Network
HONcode Principles of the Health On the Net Foundation Partners of W Macular Degeneration File
. Learn about late-breaking research from recognized experts in macular diseases at clinics and hospitals worldwide. Compiled from the National Library of Medicine database at the National Institutes of Health, the Macular Degeneration File Macular Degeneration File informs you about studies at such renowned institutions as the Wills Eye Hospital in Philadelphia, the New England Eye Center at Tufts University, and the University of London Department of Clinical Ophthalmology. The Macular Degeneration File brings you the inside medical story on: Radiation Therapy for Age-Related Macular Degeneration Surgery for AMD Phototherapy for the Treatment of AMD Laser Therapy for AMD Pharmacological Approaches to AMD Vitamin and Nutritional Supplements General Studies in Age-Related Macular Degeneration Access to Free Full-Text Articles from Postgraduate Medicine, the British Medical Journal, and the New England Journal of Medicine

149. MSNBC - Macular Degeneration Gene Found
Genetics. macular degeneration gene found. Discovery could help scientists preventblindness in old age. The Associated Press. Updated 0258 PM PT Oct. 31, 2003.
MSN Home My MSN Hotmail Shopping ... Money document.write('') Web Search: logoImg(""); MSNBC News Alerts Newsletters Help ... MSNBC Shopping Search MSNBC: Advanced Search   RESOURCE GUIDE Buy Life Insurance Yellow pages Shopping ... Small Business Tips Genetics Macular degeneration gene found Discovery could help scientists prevent blindness in old age The Associated Press Updated: 5:58 p.m. ET Oct.31, 2003 PORTLAND, Ore. - In what may be an important step toward preventing blindness in old age, scientists have identified a gene believed to be responsible for a degenerative eye disease that could strike millions of baby boomers as they grow older. advertisement
The gene is suspected of being the main cause of some cases of age-related macular degeneration, or AMD, a complex disease triggered by various factors. It typically affects people 65 and older. In age-related macular degeneration, the most sensitive area of the retina breaks down, robbing a person of the fine vision needed to read a book or recognize a face. In severe cases, it can lead to almost total blindness. About 6 million Americans suffer from AMD, a number that is predicted to double by the year 2030 as the baby boomer generation ages. There are treatments for the disease, but the goal is prevention.

150. Age-Related Macular Degeneration (AMD) - For Patients And Families - The Center
AgeRelated macular degeneration (AMD) macular degeneration Foundation PO Box 9752San Jose, CA 95157 (888) 633-3937 (408) 260-1335 http//
For Patients and Families Age-Related Macular Degeneration (AMD) What is AMD?
Age-related macular degeneration (AMD) is the most common cause of severe irreversible loss of center vision in people over the age of 55. AMD is a disorder of the retina, a thin layer of nerve tissue responsible for vision that lines the inside of the eye. AMD primarily affects a small area in the center of the retina known as the macula. Symptoms include blurred or distorted central vision. Because of these symptoms, activities such as driving, reading, writing checks and recognizing faces can be difficult. AMD appears in two forms: wet AMD and dry AMD. In wet AMD, abnormal collections of blood vessels grow under the macula. These new blood vessels have a tendency to be very fragile and often leak blood and fluid under the macula. This leakage causes rapid damage to the macula and central vision loss can occur in a short period of time. Wet AMD does not ordinarily cause loss of peripheral (side) vision. Wet AMD treatment is directed at the abnormal blood vessels under the macula. In some instances, the ophthalmologist may perform laser surgery in an attempt to prevent further vision loss. However, most patients are not candidates for laser surgery because of the size and location of the abnormal blood vessel growth. Vision loss often occurs after laser treatment due to the progression of the disease. Other wet AMD treatments are being investigated.

151. Age Related Macular Degeneration - ARMD
A graphic description of macular degeneration, its causes, treatments and relatedprocedures. macular degeneration. Overview. What causes macular degeneration?

Who is

Retina News Retina Conditions ... Treatment
Macular Degeneration
Overview Age-related macular degeneration (ARMD)
is a degenerative condition of the macula It is the most common cause of vision loss in the United States in those 50 or older, and its prevalence increases with age. AMD is caused by hardening of the arteries that nourish the retina This deprives the sensitive retinal tissue of oxygen and nutrients that it needs to function and thrive. As a result, the central vision deteriorates. This example demonstrates what a patient with advanced macular degeneration sees. Macular degeneration varies widely in severity. In the worst cases, it causes a complete loss of central vision, making reading or driving impossible. For others, it may only cause slight distortion. Fortunately, macular degeneration does not cause total blindness since it does not affect the peripheral vision. What is the difference between wet and dry macular degeneration?

152. Moorfields Eye Hospital NHS Trust : Macular Degeneration
Eye Health macular degeneration, generate a printable page printablepage. Age Related macular degeneration. macular degeneration
Home Eye Health For Patients For Health Professionals ... Diabetic Retinopathy Macular Degeneration Diagnosis Treatment AMD facts Common questions ... Eye Health Macular Degeneration printable page
Age Related Macular Degeneration
Macular degeneration accounts for almost 50% of all visual impairment in the developed world. It usually affects people over 50 years of age and is known as Age-related Macular Degeneration (ARMD or AMD). There are other forms of macular disease which affect younger people, which are often termed 'macular dystrophy' and may run in families - however, this type of macular degeneration is rare. Macular degeneration can also be caused by eye injury, infection or inflammation. Diabetes can also cause macular disease (known as diabetic retinopathy). If detected early enough laser treatment can be effective in arresting AMD in a minority of patients. For the majority of patients, however, it remains untreatable.
How will my sight be affected?
Initially only one eye may be affected and symptoms in the early stages may not be noticed since one good eye can mask the sight problem of the other eye. You may notice:
  • The central part of your vision is 'reduced'. You may see the outline of a face but not the features

153. Macular Degeneration/Dystrophies
macular degeneration/Dystrophies. The affected. Vision loss from maculardegeneration is much more than just a loss of visual acuity.
Macular Degeneration/Dystrophies The Many Visual Problems of Macular Degeneration
Richard L. Windsor, O.D., F.A.A.O.
Laura K. Windsor, O.D., F.A.A.O.
Published in Vision Enhancement Journal
P atients are diagnosed daily with macular degeneration but few patients are adequately counseled on how their vision will be affected. Vision loss from macular degeneration is much more than just a loss of visual acuity. It is important that we counsel these patients on the variety of visual problems they will encounter. Decrease of Visual Acuity: The sharpness of my vision is decreasing!” The macula is the center of our vision and when functioning properly provides our sharpest vision. In macular degeneration, this area is damaged and visual acuity of 20/20 is no longer possible. The surrounding retina can be used, but it is not as sensitive as the macula. Visual Distortion: “ I see wavy words, and the letters vary in size and look like they are distorted like in a funhouse mirror.” Damage to the retina may result in distortion and wavy vision due to the stretching and distortion to the retinal layers. Imagine you are projecting slides onto a screen when someone wrinkles the screen.

154. Eye Disease On The Horizon: Macular Degeneration In Elderly Projected To Increas
April 19, 2004. EYE DISEASE ON THE HORIZON macular degeneration INELDERLY PROJECTED TO INCREASE SUBSTANTIALLY. The number of people
Print This Page
Media Relations Staff

Broadcast Services

The News Media

Johns Hopkins Medicine
Office of Corporate Communications
Media Contact: John M. Lazarou
April 19, 2004 EYE DISEASE ON THE HORIZON: MACULAR DEGENERATION IN ELDERLY PROJECTED TO INCREASE SUBSTANTIALLY The number of people in the U.S. with age-related macular degeneration (AMD), the leading cause of blindness in people over 65, will increase from 1.75 million people to almost 3 million people by the year 2020, according to a study by researchers at Johns Hopkins and in the Eye Diseases Prevalence Research Group, a national coalition of scientists studying the frequency of eye disease in the U.S. “Treatments such as high dose vitamins and laser procedures can slow the rate of vision loss from AMD, but better therapies are urgently needed,” says David Friedman, M.D., associate professor of ophthalmology at Johns Hopkins and lead investigator of the study, which appears in the April issue of The Archives of Ophthalmology. Age-related macular degeneration is a disorder of the retina, the light-sensitive layer of cells at the back of the eye that can cause gradual vision loss, and is the leading cause of blindness among European-descended people older than 65 years. According to Friedman, the estimates are needed in order for policy planners to determine the benefit of current and future therapies.

155. Cole Eye Institute - Patient Information
Patient Information Diseases macular degeneration. Take a Tourof the Eye macular degeneration. As we age, the macula (the
Macular Degeneration
Macular Degeneration
As we age, the macula (the small part of the retina at the back of the eye that provides sharpness of vision) begins to break down and produces small white particles called drusen, which are seen in a fundus photograph and in a cross-sectional diagram above. These can be an early sign of macular degeneration, but they do not usually cause vision loss by themselves and not all patients who develop drusen go on to develop macular degeneration. The dry or atrophic form of age-related macular degeneration, seen above in fundus photography and in a cross-sectional diagram, is the most common form of macular degeneration, accounting for about 90 percent of cases. Although this form of AMD does not usually cause severe vision loss, it can progress to the wet form, so patients who have it should see their ophthalmologist regularly. The wet or exudative form of AMD, seen here in fundus photography and in a cross-sectional diagram, affects about 10 percent of AMD patients. It is caused by the growth of abnormal blood vessels at the back of the eye that can leak fluid and blood. The wet form of AMD typically causes significant vision problems in the affected eye and can progress very rapidly and cause permanent vision loss.

156. What Is Age Related Macular Degeneration?
Age related macular degeneration (ARMD) or macular degeneration, includes wet (CNV)dry (atrophic) or PED as the leading cause of significant vision loss in
Central Carolina Surgical Eye Associates, P.A. What is age related macular degeneration? Age related macular degeneration (ARMD) or macular degeneration is the leading cause of significant vision loss in people over the age of 55. The macula is the central area of the retina responsible for fine detailed vision. As we age, the macula becomes thinned and deposits called drusen are formed. This is the early form of age related macular degeneration. There are three forms of age related macular degeneration. All three forms can cause vision loss. However, they do so at different rates. Dry or atrophic macular degeneration is a slow degenerative process with gradual vision loss over many years. It may lead to severe central vision loss, but peripheral vision is not affected. The "wet" form of macular degeneration or choroidal neovascularization (CNV) usually occurs suddenly. Symptoms include blurry or fuzzy vision, straight lines such as sentences on a page or telephone poles appear wavy, distorted and dark or blank areas appear in the center of vision. Abnormal blood vessel growth (choroidal neovascularization) from underneath the retina causes this type of severe vision loss. A small percentage of these cases fall into the strict guidelines required for laser treatment to be effective. If left untreated, bleeding and scarring will lead to a profound permanent loss of central vision.

157. Science News: Slowing Macular Degeneration With Antioxidants
Washington DC macular degeneration, the leading cause of blindness inthe Western world, has no cure and no truly effective treatment.
First Effective Treatment to Slow Vision Loss
By Sean Henahan , Access Excellence
Washington DC- Macular degeneration, the leading cause of blindness in the Western world, has no cure and no truly effective treatment. Now researchers are happy to have discovered a treatment that at least slows the development of the disease in the form of a potent combination of antioxidant vitamins. The macula is at the center of the retina at the back of the eye. For reasons that have yet to be understood, sometimes the light-sensitive cells in the macula break down, resulting in a loss of central vision. In one form of the disease, the ``wet'' form, new blood vessels form behind the retina causing additional problems. Some 15 million people in the US alone have macular degeneration. Symptoms typically begin to appear when people reach their 50s and 60s. Nearly 25% of those over the age of 65 develop the disease. The early symptoms involve some blurring of vision and gradual loss of central vision. Eventually all but the outermost peripheral vision is lost. The Age-Related Eye Disease Study (AREDS) followed 4,757 older volunteers (55-80 years) with various levels of risk for developing macular degeneration in 11 clinical centers throughout the United States. Participants received either 80 milligrams of zinc oxide; an antioxidant combination including 500 milligrams of vitamin C; 400 IU of vitamin E; 15 milligrams of beta-carotene; the antioxidant combination plus zinc; or a placebo. The ongoing study began five years ago.

158. Disease Category Listing (96): Macular Degeneration
Clinical Trials macular degeneration. Arizona. Tucson; Research Site Researchstudy for patients with macular degeneration. California.
Clinical Trials: Macular Degeneration
Tucson; Research Site
Research study for patients with macular degeneration.
Beverly Hills; Research Site
Research study for patients with macular degeneration. Irvine; Research Site
Research study for patients with macular degeneration. Los Angeles; UCLA
An Open-label, Phase I, Single Administration, Dose-Escalation Study of Ad GV PEDF.11D in Neovascular Age-related Macular Degeneration (AMD) Los Angeles; Research Site
Research study for patients with macular degeneration. Menlo Park; Research Site
Research study for patients with macular degeneration. Mountain View; Research Site
Research study for patients with macular degeneration. San Diego; Research Site
Research study for patients with macular degeneration. San Francisco; Research Site
Research study for patients with macular degeneration. Santa Barbara; Research Site
Research study for patients with macular degeneration.
Danbury; Clinical Eye Research Center of Connecticut Research study for patients with Macular Degeneration. Danbury; Research Site

159. MD Support
Ê MD Support has moved to a new server. If you are not automatically redirectedwithin 5 seconds, please click here Visit MD Support. Thank you.
window.location.replace(""); MD Support has moved to a new server. If you are not automatically redirected within 5 seconds,
please click here: Visit MD Support Thank you.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Page 8     141-159 of 159    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8 

free hit counter